Amgen and Betta Pharmaceutical Co. to form joint venture.

The company will be located in Hangzhou, Zhejiang Province. Among the products for joint development and marketing are Vectibix, a humanized EGFR antibody for the treatment of colorectal cancer but requiring genetic subgroup analysis

China Bio press release, Sept. 26, 2013

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year. Accept or Deny